Denis Drygin - Net Worth and Insider Trading
Denis Drygin Net Worth
The estimated net worth of Denis Drygin is at least $27,600 dollars as of 2025-04-27. Denis Drygin is the Chief Scientific Officer of Regulus Therapeutics Inc and owns about 10,000 shares of Regulus Therapeutics Inc (RGLS) stock worth over $27,600. Details can be seen in Denis Drygin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Denis Drygin has not made any transactions after 2022-03-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Denis Drygin
Denis Drygin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Denis Drygin owns 1 companies in total, including Regulus Therapeutics Inc (RGLS) .
Click here to see the complete history of Denis Drygin’s form 4 insider trades.
Insider Ownership Summary of Denis Drygin
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| RGLS | Regulus Therapeutics Inc | 2022-03-01 | Chief Scientific Officer |
Denis Drygin Latest Holdings Summary
Denis Drygin currently owns a total of 1 stock. Denis Drygin owns 10,000 shares of Regulus Therapeutics Inc (RGLS) as of March 1, 2022, with a value of $27,600.
Latest Holdings of Denis Drygin
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RGLS | Regulus Therapeutics Inc | 2022-03-01 | 10,000 | 2.76 | 27,600 |
Holding Weightings of Denis Drygin
Denis Drygin Form 4 Trading Tracker
According to the SEC Form 4 filings, Denis Drygin has made a total of 2 transactions in Regulus Therapeutics Inc (RGLS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Regulus Therapeutics Inc is the acquisition of 7,669 shares on March 1, 2022, which cost Denis Drygin around $17,638.
Insider Trading History of Denis Drygin
- 1
Denis Drygin Trading Performance
GuruFocus tracks the stock performance after each of Denis Drygin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Denis Drygin is 4.46%. GuruFocus also compares Denis Drygin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Denis Drygin within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Denis Drygin's insider trading performs compared to the benchmark.
Performance of Denis Drygin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 34.44 | | | | | |
| Relative Return to S&P 500(%) | 33.56 | | | | | |
Denis Drygin Ownership Network
Ownership Network List of Denis Drygin
Ownership Network Relation of Denis Drygin
Denis Drygin Owned Company Details
What does Regulus Therapeutics Inc do?
Who are the key executives at Regulus Therapeutics Inc?
Denis Drygin is the Chief Scientific Officer of Regulus Therapeutics Inc. Other key executives at Regulus Therapeutics Inc include Chief Operating Officer Joseph P Hagan , Chief Financial Officer Crispina Calsada , and Sr. VP & General Counsel Christopher Ray Aker .
Regulus Therapeutics Inc (RGLS) Insider Trades Summary
Over the past 18 months, Denis Drygin made no insider transaction in Regulus Therapeutics Inc (RGLS). Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 91,634 shares made by Joseph P Hagan , a net sale of 49,272 shares made by Crispina Calsada , and a net sale of 49,103 shares made by Christopher Ray Aker .
In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 69,610 shares, with a net purchase of 69,610 shares. During the past 18 months, 271,454 shares of Regulus Therapeutics Inc (RGLS) were sold and 73,610 shares were bought by its insiders, resulting in a net sale of 197,844 shares.
Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regulus Therapeutics Inc Insider Transactions
Denis Drygin Mailing Address
Above is the net worth, insider trading, and ownership report for Denis Drygin. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Denis Drygin's mailing address is: San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
